Authors:
LOJEWSKI B
BACHER P
IQBAL O
WALENGA JM
HOPPENSTEADT D
LEYA F
FAREED J
Citation: B. Lojewski et al., EVALUATION OF HEMOSTATIC AND FIBRINOLYTIC ALTERATIONS ASSOCIATED WITHDAILY ADMINISTRATION OF LOW-MOLECULAR-WEIGHT HEPARIN FOR A 12-WEEK PERIOD, Seminars in thrombosis and hemostasis, 21(2), 1995, pp. 228-239
Authors:
BACHER P
LOJEWSKI B
IQBAL O
WALENGA JM
LEYA F
WOLF H
WELZEL D
FAREED J
Citation: P. Bacher et al., HEMOSTATIC PROFILE OF A 3 MONTHS DAILY SUBCUTANEOUS TREATMENT WITH LMW HEPARIN, Thrombosis and haemostasis, 69(6), 1993, pp. 654-654
Citation: W. Jeske et al., COMPARATIVE BIOCHEMICAL AND PHARMACOLOGICAL PROFILES OF 3 SYNTHETIC ANALOGS OF HEPARIN, Thrombosis and haemostasis, 69(6), 1993, pp. 672-672
Authors:
BACHER P
LOJEWSKI B
IQBAL O
WALENGA JM
LEYA F
WOLF H
WELZEL D
FAREED J
Citation: P. Bacher et al., DOES ANTICOAGULATION WITH HEPARIN FOLLOWED BY DAILY LONG-TERM LMW HEPARIN ACTIVATE THE FIBRINOLYTIC SYSTEM, Thrombosis and haemostasis, 69(6), 1993, pp. 829-829
Authors:
LEE TC
JESKE W
CHEN J
HWANG KM
CHOY B
LOJEWSKI B
FAREED J
Citation: Tc. Lee et al., ANTICOAGULANT AND ANTITHROMBOTIC PROFILE OF A SERIES OF NOVEL POLYSULFONATES, Thrombosis and haemostasis, 69(6), 1993, pp. 894-894
Authors:
LOJEWSKI B
BACHER P
IQBAL O
WOLF H
FAREED J
Citation: B. Lojewski et al., HEMATOLOGICAL ALTERATIONS DURING A 12 WEEK DAILY ADMINISTRATION OF A LOW-MOLECULAR-WEIGHT HEPARIN (MONO-EMBOLEX(R)) IN PRIMATES, Thrombosis and haemostasis, 69(6), 1993, pp. 1029-1029
Citation: B. Lojewski et al., MOLECULAR-WEIGHT DEPENDENCE ON THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR AFTER SUBCUTANEOUS AND INTRAVENOUS ACTIONS OF HEPARINS, Thrombosis and haemostasis, 69(6), 1993, pp. 1174-1174
Authors:
KINDEL G
BACHER P
IQBAL O
LOJEWSKI B
WALENGA JM
FAREED J
Citation: G. Kindel et al., PLATELET-MEDIATED VASOCONSTRICTION IS NOT SOLELY DEPENDENT UPON THROMBIN - AN EXPERIMENTAL-STUDY WITH R-HIRUDIN AND DEFIBROTIDE, Thrombosis and haemostasis, 69(6), 1993, pp. 1245-1245
Authors:
LOJEWSKI B
BACHER P
IQBAL O
WALENGA JM
HOPPENSTEADT DA
LEYA F
FAREED J
Citation: B. Lojewski et al., EVALUATION OF HEMATOLOGIC ALTERATIONS ASSOCIATED WITH DAILY ADMINISTRATION OF LOW-MOLECULAR-WEIGHT HEPARIN (MONO-EMBOLEX) FOR A 12-WEEK PERIOD, Seminars in thrombosis and hemostasis, 19, 1993, pp. 36-43
Authors:
JESKE W
LOJEWSKI B
WALENGA JM
HOPPENSTEADT D
AHSAN A
FAREED J
Citation: W. Jeske et al., BIOCHEMICAL AND PHARMACOLOGICAL PROFILE OF LOW-MOLECULAR-WEIGHT HEPARIN (LU 47311, CLIVARIN), Seminars in thrombosis and hemostasis, 19, 1993, pp. 229-240
Authors:
BACHER P
IQBAL O
LOJEWSKI B
WALENGA JM
LEYA F
FAREED J
Citation: P. Bacher et al., A SIMULATED POSTANGIOPLASTY LOW-MOLECULAR-WEIGHT HEPARIN SCHEDULE IN A NONHUMAN PRIMATE MODEL, Thrombosis research, 70(4), 1993, pp. 295-306